TransDigm insider to sell 1,760 shares after option exercise
Rhea-AI Filing Summary
TransDigm Group Incorporated (TDG) notice reports a proposed sale of 1,760 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $2,467,687.38. The filing shows the shares were acquired on 08/26/2025 by exercise of options under a registered plan, consisting of 820 and 940 shares respectively, with cash payment on the same date. The filer certifies no undisclosed material adverse information about the issuer and indicates no securities sold by the person in the prior three months.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider plans to sell 1,760 shares acquired by option exercise; size is immaterial relative to outstanding shares.
The filing documents a Rule 144 notice for 1,760 shares valued at $2,467,687.38 to be sold on 08/26/2025 via Morgan Stanley Smith Barney LLC. The shares were acquired the same day by exercising registered options (820 and 940 shares) and paid in cash. Relative to 56,350,285 shares outstanding, this sale represents roughly 0.003% of the float, which is unlikely to be market-moving. The filer also affirms absence of undisclosed material adverse information.
TL;DR: Routine Form 144 disclosure following option exercises; disclosure aligns with Rule 144 requirements and trading plan representations.
The report is procedural: it records acquisition by option exercise and a planned sale under Rule 144. The signature statement reiterates the filer does not possess undisclosed material information and references trading-plan/10b5-1 considerations. No prior sales in the last three months are reported, simplifying aggregation rules for compliance. From a governance perspective, the filing meets standard transparency expectations for insider dispositions.